Tag Archive for: Medical Devices

Life Science Partner is pleased to announce the recruitment of Dan Schrock to Leica Biosystems to serve as Senior Director, Global Clinical Affairs.

Leica Biosystems is a global leader in clinical diagnostics technologies providing a full suite of anatomic pathology products and laboratory workflow solutions for cancer diagnostics. Utilizing this platform, the company provides customized companion diagnostics solutions for pharmaceutical companies developing novel oncology drugs. Leica Biosystems is part of the Danaher group of companies.

Schrock previously served as Sr. Manager, Alliances with Illumina in San Diego, where he was responsible for managing corporate partnerships for the development of companion diagnostics for oncology drugs. Prior, Schrock led clinical affairs programs in IVD and CDx with Ventana Medical Systems, Abbott Laboratories, and Cepheid.

In his new role, Schrock will be responsible for overseeing Leica’s clinical research programs, providing strategic leadership to the company’s evolving clinical affairs function, and managing partnerships with pharmaceutical companies for the continued development and testing of companion diagnostics for personalized medicine.

“Companion diagnostics development is core to the Leica’s clinical strategy, so this leader must have a solid grounding in not only clinical trials leadership, but also diagnostics development and pharmaceutical partnering. It’s quite rare to see this combination of clinical trials excellence and CDx expertise in the same individual,” noted Tom Callaway, MD, MBA, President of Life Science Partner. “Dan is ideally suited for this important role and we expect him to be an asset to the company for many years to come.”

Schrock is a chemist by training and earned his Bachelors and Masters degrees in Chemistry from Illinois State University.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Mark Alvarez to Irrimax, where he will serve as Chief Executive Officer.

Irrimax is an Atlanta-based medical technology company that is redefining wound irrigation with Irrisept, the only FDA-cleared medical device for irrigation containing the proven antiseptic chlorhexidine gluconate (CHG).

Mark Alvarez

Alvarez was most recently Chairman, President & CEO of BC Technical, a healthcare services company focused on diagnostic imaging solutions for hospitals & clinics across the US. BCT was acquired in 2017 by Alpha Source, a portfolio company of Baird Capital. Prior to his BC Technical role, Mark was Chairman-Elect & COO of Microtek Medical (Nasdaq:MTMD), a global manufacturer of custom infection control products acquired by Ecolab.

“Mark is a high-energy executive who has demonstrated the ability to fund, grow, and sell small to mid-sized healthcare companies but also has held P&L responsibility in a large global medtech organization,” commented Tom Callaway, MD, MBA, President of Life Science Partner. “His strategic experience in the infection control space will be indispensable to Irrimax during this important inflection point in the company’s growth.”

Alvarez earned a MBA from Illinois State University, a Bachelor’s degree in Biology from the University of Louisville, and has completed multiple executive programs at the GE Leadership Institute. He is a former professional tennis player and lives in Atlanta.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Caitlyn Seidl to K2M, where she will serve as Director, Regulatory & Clinical Affairs.

Based in Leesburg, Virginia, K2M is a medical device company focused on creating tools and implants for minimally-invasive spine surgery. The company is a leader in the 3D printing of spinal implants for deformity (especially scoliosis), trauma, and tumor operations. Reporting to the Senior Vice President of Global Quality and Regulatory Affairs, Seidl will be responsible for directing global clinical outcomes research programs and the global regulatory process for K2M’s product portfolio.

Previously, Seidl served as Manager, Clinical Affairs for the Critical Care division of Edwards Lifesciences, a leader in artificial heart valves and related technologies. Seidl has also held clinical affairs leadership positions with Exactech (orthopedic devices), Axogen (biologics), and Cardioquest (cardiovascular research). She brings to K2M more than a decade of clinical and regulatory affairs leadership including trials in spinal orthopedics.

“Caitlyn impressed us as a leader with both the technical acumen in clinical trials for spinal orthopedic devices and the team management skills to ensure the group’s clinical studies faithfully convey the value K2M’s technologies bring to patients,” shared Tom Callaway, MD, MBA, President of Life Science Partner. “She will be a great asset to K2M and we look forward to seeing her impact over the coming years.”

Seidly earned her bachelor’s degree in Biomedical Sciences from the University of South Florida.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Pamela Goldberg to lead the Medical Device Innovation Consortium as President and Chief Executive Officer.

Prior to starting her own consulting firm in 2017, Ms. Goldberg served as the CEO of the Massachusetts Technology Collaboration, a public economic development engine designed to foster technological advancements, where she helped launch Massachusetts to national leadership for adoption and interoperability of electronic medical records and collaborated to build the health information exchange connection to the EHR.

She will succeed Bill Murray as CEO, whom Life Science Partner recruited at the organization’s inception, and is well-suited to lead MDIC into its next phase of growth and impact, building on the foundational successes of Mr. Murray and his team.

Pamela Goldberg

“Pamela’s solid entrepreneurial experience synergizing objectives for multiple government and for-profit institutions, combined with her successful leadership experience in digital health advancements, leveraging big data, and advancing healthcare technological innovation, make her uniquely suited to lead this pioneering organization,” said Tom Callaway, MD, Founder and President of Life Science Partner. “We are confident MDIC and the many stakeholders it serves will benefit greatly from her thoughtful leadership in the months and years to come.”

Ms. Goldberg has demonstrated consistent success in working across the boundaries of government, in both non-profit and private industry and with regulatory bodies to drive consensus. Previously, Ms. Goldberg served as director of The Center for Entrepreneurial Leadership at Tufts University, a program she launched to drive innovation for the university. Ms. Goldberg received her BA from Tufts University and her MBA from Stanford University.

The MDIC, through its public-private partnership between government and regulatory agencies, non-profits, and the medical device industry, aims to advance regulatory science and bring innovative technologies to patients. MDIC coordinates the development of methods, tools, and resources used in managing the medical device life cycle to improve patient access to cutting-edge medical technology.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders.

MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

More information is available here.

Former Director, Global Sales Operations at Terumo BCT

Brigham Briggs has joined Smiths Medical as Vice President, Global Sales Operations – a newly created role for the company where Briggs will have responsibility over the sales organization worldwide. He will oversee the standardization of the sales pipeline, funnel management and incentive compensation across Smiths Medical’s sites around the globe.

Smiths Medical is a global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the hospital, emergency, home and specialist environments.

Briggs is well-equipped to lead Smiths’ sales operations after directing the worldwide sales operations, sales excellence, and Customer Centric Initiative for Terumo BCT, a medical device equipment manufacturer focused on blood processing technologies. Earlier, Briggs served as Executive Director, Commercial Operations for GreatBatch Medical where he led a global sales team driving business development, customer support, and revenue growth.

Earlier in his sales career Briggs served in sales leadership roles at American Medical System and Boston Scientific. Before joining the medical device industry, Briggs was a Captain for the US Air Force for Aircraft Maintenance and Logistics.

Briggs earned his Bachelor of Science Degree in Engineering from the United States Air Force Academy. He completed his Master of Science Degree in Logistics Management from the Air Force Institute of Technology and is Six Sigma Black Belt Certified.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Life Science Partner recruited Rachael Fleurence, PhD, to serve as the MDIC’s Executive Director, Coordinating Center in partnership with the National Evaluation System for Health Technology (NEST).

MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science. MDIC is a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment. The U.S. Food and Drug Administration (FDA) has awarded the MDIC $3 million in seed funding to establish the Coordinating Center for the Medical Device National Evaluation System for health Technology (NEST).

While at PCORI, Fleurence lead the launch of PCORnet, a national patient centered research network consisting of 130 institutions and patient groups nationwide. She also directed the Clinical Research Methods program in areas including comparative effectiveness research, methods for patient engagement and research prioritization and analytical methodologies.

“The initial phase of the NEST project will include demonstration projects piloting methods for tracking medical device data and patient-reported outcomes through the use of real-world evidence., Fleurence has the unique capability to lead the vision and execution of the MDIC’s Coordinating Center in partnership with NEST,” states Tom Callaway, MD, Founder of Life Science Partner.

Rachael Fleurence earned her Bachelor of Arts Degree in Social and Political Science from University of Cambridge, UK, and her MA in business management from ESSEC- Paris. She completed her Master of Science and PhD in health economics from the University of York. She also completed her AMIA 10X10 Bioinformatics Certificate from the Oregon Health and Sciences University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Former Director, Business Development at Erdman

Tony Brennan has joined Underwriters Laboratories as Director, North American Sales for the company’s Health Sciences business unit reporting to Upayan SenGupta, Vice President, General Manager, Health Sciences—SenGupta was recruited to UL by Life Science Partner in 2015. Brennan previously served as Director, Business Development for Erdman, a consulting firm dedicated to providing integrated solutions for healthcare clients.

Brennan’s career has been focused on building and leading strategic healthcare sales teams and cultivating key relationships with Group Purchasing Organizations and Integrated Delivery Networks. He has previously held sales leadership roles at HeartSine Technologies, Angelica, Cardionow, Cordis and GE Healthcare.

In his role at UL, Brennan will oversee the sales and new business development for the company’s rapidly growing Health Sciences Division. Brennan will be lead the transformation of the business from selling traditional compliance and audit services to becoming a proactive partner in the registration and product development teams for UL’s clients.

Brennan earned his Bachelor of Science in Biology and Chemistry from Bowling Green State University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Former Senior Director, Global Quality Operations Mylan Pharmaceuticals

Life Science Partner recruited Deva Puranam, MSc, MBA, to serve as Vice President, Global Laboratory Operations at Baxter International to lead the company’s laboratory standardization practices and build out quality systems infrastructure across Baxter’s lab facilities worldwide.

Puranam joins Baxter after serving as Senior Director, Global Quality Operations for Mylan where he was responsible for implementing seamless harmonization for laboratory operational processes overseeing a team of 109 employees spanning across 33 manufacturing sites globally.

“With an enthusiastic communication style that underlies a highly competent individual who can win the respect of others, Puranam will be successful at building the next generation of quality managers at Baxter while improving quality assurance initiatives to exceed regulatory agency inspections worldwide,” states Tom Callaway, MD, Founder and President of Life Science Partner.

Puranam earned his Bachelor’s Degree in Mathematics, Physics and Chemistry and his Master of Science Degree in Organic Chemistry from Andhra University in India in 1991 and 1995. He completed his MBA in Marketing and Management Information Systems (Operations Research Ancillary) from the University of Madras.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Former Vice President, Global Clinical Affairs, Zimmer Biomet

Life Science Partner recruited Jing Xie, PhD, MS, former Vice President, Global Clinical Affairs for Zimmer Biomet to become the Medical Device Innovation Consortium’s (MDIC) first Vice President, Clinical Affairs.

MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science to expedite development, assessment, and review of innovative medical technologies. The overall mission of the MDIC is to support the FDA’s vision to achieve first in the world patient access in the US and to assure the safety and effectiveness of medical devices through the Total Product Life Cycle.

Xie takes on her new role at the MDIC after having oversight of approximatively 300 clinical projects worldwide for Zimmer Biomet. She possesses a highly successful track record in the orthopedic industry for delivering on objectives, while maintaining effective collaboration with internal and external stakeholders.

“With a global understanding around clinical trial management including data integration for regulatory agencies across the US, Europe and Asia, Xie is a well-seasoned leader to execute the clinical affairs initiatives at the MDIC,” states Tom Callaway, MD, Founder and President of Life Science Partner.

Jing Xie earned her Bachelor of Science Degree in Analytical Chemistry from Xiamen University in China and completed her PhD in Materials Science from the University of Alabama. She holds an MS in Computer Science from Purdue University and an MS in Chemistry from the University of Alabama.

Former Senior Director, Global Quality Assurance Haemonetics Corporation

Scott Cohn was recruited by Life Science Partner to serve as Surgical Specialties’ Vice President, Global Quality Assurance where he will build a quality systems team and implement the harmonization of Surgical Specialties’ quality operations across its manufacturing facilities worldwide.

Cohn joins Surgical Specialties after serving as Senior Director, Global Quality Assurance for Haemonetics Corporation where he led the company’s initiative to improve and drive quality standards to the next level from their global contract manufacturers and suppliers.

As a hands-on leader, Cohn played a key role during Haemonetics acquisition of Pall Medical as he led the stabilization and integration activities to synchronize quality systems and operations for maximum efficiency and quality measures.

“As a results-driven quality management expert with a track record for bringing underperforming plants up to international standards, Cohn will be an essential change-agent leader for Surgical Specialties’ manufacturing operations,” states Tom Callaway, MD, Founder and President of Life Science Partner.

Scott Cohn earned his Bachelor of Science Degree in Business Management in 1991 from Southern Connecticut State University in New Haven.